Skip to content

Enbrel

DRUG20 trials

Sponsors

National Eye Institute (NEI), The University of Texas Health Science Center at San Antonio, Amgen, The Cleveland Clinic, Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Ankylosing SpondylitisArthritis, RheumatoidAxial SpondyloarthritisBone CancerChronic Stable Plaque PsoriasisHealthyJuvenile Rheumatoid ArthritisLung Cancer

Phase 1

Phase 2

Phase 3

Phase 4

Unknown Phase

Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
CompletedNCT00245934
Wyeth is now a wholly owned subsidiary of PfizerRheumatoid Arthritis
Start: 2003-06-30End: 2005-07-31Target: 1500Updated: 2007-12-14
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
CompletedNCT01188655
PfizerSpondylitis, Ankylosing
Start: 2008-05-31End: 2010-03-31Updated: 2011-09-12
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
TerminatedNCT01411215
PfizerAnkylosing Spondylitis, Rheumatoid Arthritis
Start: 2011-01-31End: 2013-01-31Updated: 2014-03-06
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
CompletedNCT01421303
PfizerAnkylosing Spondylitis
Start: 2009-10-31End: 2013-12-31Updated: 2014-12-12
Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel
CompletedNCT03100734
BiogenAxial Spondyloarthritis, Rheumatoid Arthritis
Start: 2017-06-01End: 2018-11-30Updated: 2021-02-05
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
CompletedNCT04398732
PfizerPlaque Psoriasis
Start: 2020-07-05End: 2020-10-01Updated: 2021-11-01
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
CompletedNCT04428424
PfizerArthritis, Rheumatoid
Start: 2020-07-05End: 2020-08-30Updated: 2021-09-09
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
CompletedNCT04428502
PfizerPsoriatic Arthritis
Start: 2020-07-05End: 2020-08-30Updated: 2021-09-14
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
CompletedNCT04428411
PfizerPlaque Psoriasis
Start: 2020-07-05End: 2020-08-30Updated: 2021-10-25

Related Papers